Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Scandinavian Journal of Clinical and Laboratory Investigation|September 1, 1990
Prevalence of anti-insulin antibodies and its relation to severe hypoglycaemia in insulin-treated diabetic patientsR Wredling, P E Lins, U Adamson
Diabetes Research and Clinical Practice|January 1, 1993
Factors influencing the clinical outcome of continuous subcutaneous insulin infusion in routine practiceR Wredling, P E Lins, U Adamson
Diabete & Metabolisme|September 1, 1991
Variation of insulin absorption during subcutaneous and peritoneal infusion in insulin-dependent diabetic patients with unsatisfactory long-term glycaemic response to continuous subcutaneous insulin infusionR Wredling, D Liu, P E Lins, et al.
Diabetologia|March 1, 1990
Permanent neuropsychological impairment after recurrent episodes of severe hypoglycaemia in manR Wredling, S Levander, U Adamson, et al.
Diabetes & Metabolism|November 23, 2007
A morning dose of insulin glargine prevents nocturnal ketosis after postprandial interruption of continuous subcutaneous insulin infusion with insulin lisproU B Johansson, R Wredling, U Adamson, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 1, 1991
Experience of long-term intraperitoneal insulin treatment using a new percutaneous access deviceR Wredling, U Adamson, P E Lins, et al.
Diabetes Research and Clinical Practice|March 1, 1993
How accurate are home blood-glucose meters with special respect to the low glycemic range?E Moberg, S Lundblad, P E Lins, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 5, 2003
A repeated cross-sectional survey of severe hypoglycaemia in 178 Type 1 diabetes mellitus patients performed in 1984 and 1998J Bragd, U Adamson, P-E Lins, et al.
Diabetes Research and Clinical Practice|April 1, 1991
Insulin absorption is faster when keeping the infusion site in use for three days during continuous subcutaneous insulin infusionD Liu, E Moberg, R Wredling, et al.
Acta Medica Scandinavica|January 1, 1988
Glibenclamide improves the response to insulin treatment in non-insulin-dependent diabetics with second failure to sulfonylurea therapyP E Lins, S Lundblad, E Persson-Trotzig, et al.
Pageof 14